top of page
Solaris Pharma Corporation is a leading specialty pharmaceutical company committed to the identifying, developing and marketing of high-quality, complex, generic and specialty pharmaceutical products.
WHO WE ARE
Solaris Pharma Corporation is a leading specialty pharmaceutical company committed to the identifying, developing and marketing of complex high-quality, generic and specialty pharmaceutical products. Solaris Pharma Corporation employs an experienced R&D and management team focused on right-first-time development while maintaining the highest quality standards. With a strong financial position and employee centric focus, the company strives to be a pacesetter in the niche pharmaceutical market.
Solaris Pharma Corporation is dedicated to developing a broad portfolio of complex generic and specialty pharmaceutical products to provide patients with alternative options for high quality, affordable, effective, generic and value-added products.
WHAT WE DO
Our pipeline which encompasses products from multiple dosage forms include but not limited to sterile, dermatological, tablet products among others which are challenging to develop and manufacture with complexities arising from formulation & process development, regulatory hurdles, stability and scale up.
Solaris Pharma Corporation benefits from its technical expertise in the development of specialized generic & branded complex pharmaceutical products many of which have significant scientific and regulatory hurdles. With its committed and well-trained scientific personnel, Solaris Pharma Corporation is currently developing several products in the sterile, topical, tablet dosage forms among others, which are in different stages of development.
Meet Our Team
News & Events
Mar 20, 2023 - Solaris Pharma Corporation located Bridgewater, New Jersey is pleased to announce the approval of Tazarotene Gel, 0.05% and 0.1%. To know learn more about Solaris News/Events....
bottom of page